1311138-07-4

Basic information

• Product Name: 6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinamine
• Synonyms: 6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinamine
• CAS NO: 1311138-07-4
• Molecular Weight: 230.266
• Mol File: 1311138-07-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinamine(CAS DataBase Reference)
• NIST Chemistry Reference: 6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinamine(1311138-07-4)
• EPA Substance Registry System: 6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinamine(1311138-07-4)

Safety Data

• Hazardous Substances Data: 1311138-07-4(Hazardous Substances Data)

Upstream product

• 4548-45-2 2-chloro-5-nitropyridine 
• 1311138-06-3 2-{[4-methyl-3-(methyloxy)phenyl]oxy}-5-nitropyridine 
• 13120-77-9 2-methyl-5-nitroanisole 
• 16452-01-0 ortho-cresidine 
• 19217-50-6 4-methyl-3-(methyloxy)phenol 

Downstream Products

• 1311138-54-1 1,1-dimethylethyl (1-{[(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)amino]carbonyl}cyclobutyl)carbamate 
• 1311138-52-9 1,1-dimethylethyl ((1R)-1-methyl-1-{[(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)amino]carbonyl}propyl)carbamate 
• 1311138-25-6 1,1-dimethylethyl ((1S)-1-{[(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)amino]carbonyl}propyl)carbamate 
• 1311138-08-5 1,1-dimethylethyl {(1R)-1-methyl-2-[(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)amino]-2-oxoethyl}carbamate 
• 1311138-22-3 1,1-dimethylethyl ((1R)-1-{[(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)amino]carbonyl}propyl)carbamate 
• 1311138-50-7 1,1-dimethylethyl ((1R)-2,2-dimethyl-1-{[(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)amino]carbonyl}propyl)carbamate 
• 1311138-26-7 (2S)-2-amino-N-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)butanamide 
• 1311138-51-8 3-methyl-N'-(6-{[4-methyll-3-(methyloxy)phenyl]oxy}-3-pyridinyl)-D-valinamide 
• 1311138-55-2 1-amino-N-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)cyclobutanecarboxamide 
• 1311136-80-7 (5R)-5-methyl-3-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}3-pyridinyl)-2,4-imidazolidinedione 
• 1311136-84-1 (5R)-5-ethyl-3-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)-2,4-imidazolidinedione 
• 1311136-86-3 (5S)-5-ethyl-3-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)-2,4-imidazolidinedione 
• 1311136-95-4 (5R)-5-(1-methylethyl)-3-(4-{[4-methyl-3-(methyloxy)phenyl]oxy}phenyl)-2,4-imidazolidinedione 
• 1311136-98-7 (5R)-5-(1,1-dimethylethyl)-3-(6-{[4-methyl-3-(methyloxy)phenyl]oxy}-3-pyridinyl)-2,4-imidazolidinedione 

Relevant articles and documents

KV3 ENHANCERS FOR THE TREATMENT OF COGNITIVE DISORDERS

The invention provides new heterocyclic compounds having the general formula (I) wherein A, B, L, Y1 to Y4 and R1 to R6 are as described herein.

HYDANTOIN DERIVATIVES USEFUL AS KV3 INHIBITORS

The invention provides compounds of formula (I): Said compounds being inhibitors of Kv3 channels and of use in the prophylaxis or treatment of related disorders.